- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
Esbriet is an anti fibrotic drug used to treat idiopathic pulmonary fibrosis (IPF) by inhibiting pro fibrotic factors, reducing oxidative stres...
During the treatment of pirfenidone, attention should be paid to the three major risks of photosensitivity, hepatotoxicity, and gastrointestina...
The contraindications for pirfenidone mainly include severe liver and kidney dysfunction, pregnant women, and patients with specific physiologi...
Among the common side effects of pirfenidone, nausea, rash, and fatigue can be effectively alleviated by adjusting medication methods, symptoma...
The administration of Futibatinib should strictly follow the principle of fasting, and the dosage should be adjusted according to adverse react...
Targeted management measures are needed for common side effects such as diarrhea, stomatitis, and fatigue during treatment with Futibatinib. Th...
Futibatinib has clear contraindications for patients with severe liver and kidney dysfunction and eye lesions, and strict risk assessment is re...
Futibatinib is an irreversible FGFR inhibitor primarily used to treat patients with unresectable biliary tract cancer carrying FGFR2 gene fusio...
The potential side effects of Suimeikai, such as insomnia, headache, and nausea, require targeted management: insomnia can be improved by adjus...
The contraindications for Triumeq mainly include HLA-B * 5701 gene positive patients and patients with severe liver disease. The use of this dr...
